Birchview Capital, LP Corcept Therapeutics Inc Transaction History
Birchview Capital, LP
- $108 Million
- Q3 2024
A detailed history of Birchview Capital, LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Birchview Capital, LP holds 74,000 shares of CORT stock, worth $5.45 Million. This represents 3.16% of its overall portfolio holdings.
Number of Shares
74,000
Previous 74,000
-0.0%
Holding current value
$5.45 Million
Previous $2.4 Million
42.39%
% of portfolio
3.16%
Previous 2.4%
Shares
4 transactions
Others Institutions Holding CORT
# of Institutions
385Shares Held
86.2MCall Options Held
1.39MPut Options Held
879K-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$745 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$596 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$456 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$282 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.88B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...